Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01839773 | Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer(DREAM) | completed | Phase 3 | 238 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 25, 2024 | clinicaltrials |
| NCT04600518 | Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer(SPRINT) | completed | — | 2,047 | Novomics. Co., Ltd.INDUSTRY |
| 1 |
| Jul 22, 2024 |
| clinicaltrials |
| NCT06510088 | Effects of Multimodal Prehabilitation on Frail Elderly Patients Undergoing Elective Gastric Cancer Surgery | completed | N/A | 112 | Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical UniversityOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06506331 | Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical Gastrectomy | completed | — | 490 | Fujian Medical UniversityOTHER | 0 | Jul 17, 2024 | clinicaltrials |
| NCT06342427 | Stomach Cancer Exosome-based Detection(DESTINEX) | completed | — | 809 | City of Hope Medical CenterOTHER | 2 | Jul 8, 2024 | clinicaltrials |
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | completed | Phase 4 | 431 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06477562 | Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction. | completed | — | 160 | Saint Vincent's Hospital, KoreaOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT02310230 | An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy | completed | N/A | 100 | Donald MathewsOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05688761 | Nordic Gastric and Esophageal Tumor Study(NordGETS) | completed | — | 900,000 | Karolinska InstitutetOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06467591 | Prediction Model for Advanced Gastric Cancer in Elderly | completed | — | 1,436 | Chang-Ming Huang, Prof.OTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT04808791 | iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | completed | Phase 2 | 7 | AHS Cancer Control AlbertaOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT04360577 | Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy | completed | N/A | 240 | Guangzhou University of Traditional Chinese MedicineOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT03382600 | Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) | completed | Phase 2 | 100 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Jun 11, 2024 | clinicaltrials |
| NCT03471494 | GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery(GS3) | completed | — | 15,958 | University of EdinburghOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT05518929 | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients(SpO2) | completed | Phase 4 | 1,090 | RenJi HospitalOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT02318329 | Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors | completed | Phase 1 | 79 | Five Prime Therapeutics, Inc.INDUSTRY | 3 | Jun 4, 2024 | clinicaltrials |
| NCT04400383 | Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors | completed | Phase 1 | 62 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | May 24, 2024 | clinicaltrials |
| NCT06412575 | JNT Versus TNT to Guided OGT-overlap Oesophagojejunostomy | completed | N/A | 108 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06250075 | Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer(PRONIC-G) | completed | N/A | 88 | Universidade Federal do AmazonasOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT05714878 | Multimodal Prehabilitation for Resectable Gastric Cancer | completed | N/A | 70 | Chinese PLA General HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03957031 | Gastric Cancer Risk Factors Associated With EU and CELAC Populations(LEGACY-1) | completed | — | 1,600 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT04015466 | Advanced GC Multi-omic Characterization in EU and CELAC Populations(LEGACY-2) | completed | — | 800 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT04019808 | Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population(LEGACY-3) | completed | — | 800 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT04835896 | Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer | completed | Phase 1 / Phase 2 | 49 | Yonsei UniversityOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02267343 | Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer | completed | Phase 3 | 493 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 3 | May 3, 2024 | clinicaltrials |
| NCT02746796 | Study of ONO-4538 in Gastric Cancer | completed | Phase 2 / Phase 3 | 680 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 3 | May 3, 2024 | clinicaltrials |
| NCT03006705 | Study of Adjuvant ONO-4538 With Resected Gastric Cancer | completed | Phase 3 | 800 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 4 | May 3, 2024 | clinicaltrials |
| NCT06393153 | Model for Prognosis of Elderly Gastric Cancer Patients | completed | — | 1,202 | Chang-Ming Huang, Prof.OTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04985084 | Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer Survivors | completed | N/A | 35 | The Hong Kong Polytechnic UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06392750 | PWP1's Expression in Gastric Cancer. | completed | — | 200 | Northern Jiangsu People's HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT04742959 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 203 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04002128 | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery | completed | N/A | 120 | Osijek University HospitalOTHER | 0 | Apr 23, 2024 | clinicaltrials |
| NCT03330561 | PRS-343 in HER2-Positive Solid Tumors | completed | Phase 1 | 85 | Pieris Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT03650348 | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors | completed | Phase 1 | 41 | Pieris Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT05336058 | Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer | completed | — | 1,140 | Singlera Genomics Inc.INDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT06376773 | Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. | completed | — | 234 | Fujian Medical UniversityOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05540145 | Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma | completed | — | 70 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06365814 | ERAS for Gastric Cancer Patients After NACT | completed | — | 252 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT04768218 | BLI for the Diagnosis of Precancerous Conditions | completed | — | 102 | Instituto Portugues de Oncologia, Francisco Gentil, PortoOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06337266 | A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma | completed | — | 3,622 | Fujian Medical UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06337279 | Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk | completed | — | 3,820 | Fujian Medical UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT05035602 | Google Location History Following Oesophagectomy and/or Gastrectomy | completed | — | 3 | Imperial College LondonOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT04547153 | Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC | completed | Phase 2 | 24 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT01924533 | Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. | completed | Phase 3 | 525 | AstraZenecaINDUSTRY | 4 | Mar 22, 2024 | clinicaltrials |
| NCT05030870 | Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients(CapnoGI) | completed | N/A | 1,800 | RenJi HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03342937 | KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer | completed | Phase 2 | 36 | Duke UniversityOTHER | 1 | Mar 13, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jul 25, 2024source: clinicaltrials